DOCSLIB.ORG

Dr Moni Kumari 28/04/2020 B.Sc. 3Rd and M.Sc. 3Rd Semester Transcriptional Regulation in Prokaryotes Gene Is of Two Types

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr Moni Kumari 28/04/2020 B.Sc. 3Rd and M.Sc. 3Rd Semester Transcriptional Regulation in Prokaryotes Gene Is of Two Types Dr Moni Kumari 28/04/2020 B.Sc. 3rd and M.Sc. 3rd Semester Transcriptional regulation in prokaryotes Gene is of two types Housekeeping genes/ constitutive gene: transcribed continually OR transcribed at a relatively constant level o Constitutive genes that are required for the maintenance of basic cellular function for the existence of cell. o Example actin, Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ubiquitin, transcriptional factors, insulin Facultative gene: transcribed when needed/ when a cell receives a signal from its surroundings. o Expression is influenced by environmental factors. Gene expression is the process by which the heritable information in a gene, the sequence of DNA base pairs, is made into a functional gene product, such as protein or RNA. The basic idea is that DNA is transcribed into RNA, which is then translated into proteins. Each cell expresses, or turns on, only a fraction of its genes. The rest of the genes are repressed, or turned off. The process of turning genes on and off is known as gene regulation Transcriptional regulation is the means by which a cell regulates the conversion of DNA to RNA (transcription), thereby coordinating gene activity. The regulation of transcription is a vital process in all living organisms. Transcriptional regulation – controlling the rate of gene transcription for example by helping or hindering RNA polymerase binding to DNA Gene upregulation: activation, or promotion – increase the rate of gene transcription Gene down-regulation repression, or suppression – decrease the rate of gene transcription There are many classes of regulatory DNA binding sites known as enhancers, insulators and silencers collectively called response element Transcription factors (TFs) are regulatory proteins whose function is to activate (or more rarely, to inhibit) or in layman terms control the rate of transcription by binding to specific DNA sequences. Domains of TFs are DBD, SSD, TAD 1. DBD: recognizes double- or single-stranded DNA 2. SSD: allows signaling molecules to bind the transcription factor 3. TAD: The transactivation domain (TAD) is where other proteins (co-regulatory proteins) bind to the transcription factor TFs turn on and off-genes in order to make sure that they are expressed in the right cell at the right time and in the right amount throughout the life of the cell and the organism A transcriptional activator is a protein that increases gene transcription of a gene or set of genes. Most activators are DNA-binding proteins that bind to enhancers or promoter- proximal elements. A transcriptional repressor is a DNA or RNA-binding protein that inhibits the expression of one or more genes by binding to the operator or associated silencers. A DNA-binding repressor blocks the attachment of RNA polymerase to the promoter, thus preventing transcription of the genes into messenger RNA. An RNA-binding repressor binds to the mRNA and prevents translation of the mRNA into protein. This blocking of expression is called repression. WAYS OF WORKING TF work alone If the transcription rate is up-regulating then TFs with other proteins in a complex, by promoting (as an activator) If the transcription rate is down-regulating then TFs with other proteins call repressor and form a complex TF+ACTIVATOR/REPRESSOR COMPLEX RECRUIT RNA POLYMERASE Transcription factors are proteins possessing domains that bind to the DNA of promoter or enhancer regions of specific genes. They also possess a domain that interacts with RNA polymerase II or other transcription factors and consequently regulates the amount of messenger RNA (mRNA) produced by the gene. TFs have defined DNA-binding domains with up to 106-fold higher affinity for their target sequences than for the remainder of the DNA strand. Coactivators A Coactivators is a type of transcriptional coregulator that binds to an activator (a transcription factor) to increase the rate of transcription of a gene or set of genes A protein that works with transcription factors and activators to increase the rate of gene transcription Corepressor: A Corepressor is a molecule that can bind to repressor and make it bind to the operator tightly, which decreases transcription TFs+repressor+corepressor decrease the rate of gene transcription LAC OPERON The lac operon is an operon, or group of genes with a single promoter (transcribed as a single mRNA). The genes in the operon encode proteins that allow the bacteria to use lactose as an energy source. The lactose operon (lac operon) is an operon required for the transport and metabolism of lactose in E. coli and many other enteric bacteria. The gene product of lacZ is β-galactosidase which cleaves lactose, a disaccharide, into glucose and galactose When lactose is present, the lac genes are expressed because allolactose binds to the Lac repressor protein and keeps it from binding to the lac operator. Allolactose is an isomer of lactose. RNA polymerase can then bind to the promoter and transcribe the lac genes. The lac operon of E. coli contains genes involved in lactose metabolism. It's expressed only when lactose is present and glucose is absent. Two regulators turn the operon "on" and "off" in response to lactose and glucose levels: the lac repressor and catabolite activator protein (CAP). The lac repressor acts as a lactose sensor. It normally blocks transcription of the operon, but stops acting as a repressor when lactose is present. The lac repressor senses lactose indirectly, through its isomer allolactose. Catabolite activator protein (CAP) acts as a glucose sensor. It activates transcription of the operon, but only when glucose levels are low. CAP senses glucose indirectly, through the "hunger signal" molecule cAMP. STRUCTURE OF LAC OPERON Glucose control is accomplished because a glucose breakdown product inhibits formation of the CAP-cAMP complex required for RNA polymerase to attach at the lac promoter site When lactose is not available, the lac repressor binds tightly to the operator, preventing transcription by RNA polymerase. However, when lactose is present, the lac repressor loses its ability to bind DNA. It floats off the operator, clearing the way for RNA polymerase to transcribe the operon Glucose present, lactose absent: No transcription of the lac operon occurs. That's because the lac repressor remains bound to the operator and prevents transcription by RNA polymerase. Also, cAMP levels are low because glucose levels are high, so CAP is inactive and cannot bind DNA. Glucose present, lactose present: Low-level transcription of the lac operon occurs. The lac repressor is released from the operator because the inducer (allolactose) is present. cAMP levels, however, are low because glucose is present. Thus, CAP remains inactive and cannot bind to DNA, so transcription only occurs at a low, leaky level. Glucose absent, lactose absent: Transcription of the lac operon occurs. cAMP levels are high because glucose levels are low, so CAP is active and will be bound to the DNA. However, the lac repressor will also be bound to the operator (due to the absence of allolactose), acting as a roadblock to RNA polymerase and preventing transcription. Glucose absent, lactose present: Strong transcription of the lac operon occurs. The lac repressor is released from the operator because the inducer (allolactose) is present. cAMP levels are high because glucose is absent, so CAP is active and bound to the DNA. CAP helps RNA polymerase bind to the promoter, permitting high levels of transcription. Summary of lac operon responses .
Load more

Recommended publications
  • Galactosidase
    Copyright 0 1988 by the Genetics Society of America Effects of Amino Acid Substitutions atthe Active Site in Escherichia coli @-Galactosidase Claire G. Cupples and Jeffrey H. Miller Molecular Biology Institute and Department of Biology, University of Calqornia, Los Angeles, Calqornia 90024 Manuscript received April 2 1, 1988 Accepted July 23, 1988 ABSTRACT Forty-nine amino acid substitutions were made at four positions in the Escherichia coli enzyme p- galactosidase; three of the four targeted amino acids are thought to be part of the active site. Many of the substitutions were made by converting the appropriate codon in lacZ to an amber codon, and using one of 12 suppressor strains to introduce the replacement amino acid. Glu-461 and Tyr-503 were replaced, independently, with 13 amino acids. All 26 of the strains containing mutant enzymes are Lac-. Enzyme activity is reduced to less than 10% of wild type by substitutions at Glu-461 and to less than 1% of wild type by substitutions at Tyr-503. Many of the mutant enzymes have less than 0.1 % wild-type activity. His-464 and Met-3 were replaced with 1 1and 12 amino acids, respectively. Strains containing any one of these mutant proteins are Lac+. The results support previous evidence that Glu-46 1 and Tyr-503 areessential for catalysis, and suggest that His-464 is not part of the active site. Site-directed mutagenesis was facilitated by construction of an fl bacteriophage containing the complete lacz gene on i single ECORIfragment. -GALACTOSIDASE (EC 3.2.1.23) is produced in and J.
    [Show full text]
  • CHD7 Represses the Retinoic Acid Synthesis Enzyme ALDH1A3 During Inner Ear Development
    CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development Hui Yao, … , Shigeki Iwase, Donna M. Martin JCI Insight. 2018;3(4):e97440. https://doi.org/10.1172/jci.insight.97440. Research Article Development Neuroscience CHD7, an ATP-dependent chromatin remodeler, is disrupted in CHARGE syndrome, an autosomal dominant disorder characterized by variably penetrant abnormalities in craniofacial, cardiac, and nervous system tissues. The inner ear is uniquely sensitive to CHD7 levels and is the most commonly affected organ in individuals with CHARGE. Interestingly, upregulation or downregulation of retinoic acid (RA) signaling during embryogenesis also leads to developmental defects similar to those in CHARGE syndrome, suggesting that CHD7 and RA may have common target genes or signaling pathways. Here, we tested three separate potential mechanisms for CHD7 and RA interaction: (a) direct binding of CHD7 with RA receptors, (b) regulation of CHD7 levels by RA, and (c) CHD7 binding and regulation of RA-related genes. We show that CHD7 directly regulates expression of Aldh1a3, the gene encoding the RA synthetic enzyme ALDH1A3 and that loss of Aldh1a3 partially rescues Chd7 mutant mouse inner ear defects. Together, these studies indicate that ALDH1A3 acts with CHD7 in a common genetic pathway to regulate inner ear development, providing insights into how CHD7 and RA regulate gene expression and morphogenesis in the developing embryo. Find the latest version: https://jci.me/97440/pdf RESEARCH ARTICLE CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development Hui Yao,1 Sophie F. Hill,2 Jennifer M. Skidmore,1 Ethan D. Sperry,3,4 Donald L.
    [Show full text]
  • Oncjuly3 6..6
    Oncogene (1999) 18, 4137 ± 4143 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site Takeshi Suzuki1, Masami Uchida-Toita1 and Mitsuaki Yoshida*,1 1Department of Cellular and Molecular Biology, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan Tax protein of human T-cell leukemia virus type 1 Tax was originally identi®ed as a transcriptional (HTLV-1) is a potent transcriptional regulator which can activator for viral gene expression and then was shown activate or repress speci®c cellular genes and has been to activate a wide variety of cellular genes (Yoshida et proposed to contribute to leukemogenic processes in al., 1995). Tax was also demonstrated to inhibit adult T-cell leukemia. The molecular mechanism of Tax- expression of several genes. In addition to the mediated trans-activation has been well investigated. transcriptional deregulation, we found that Tax binds However, trans-repression by Tax remains to be studied to p16ink4a protein, a cyclin-dependent kinase (CDK) in detail, although it is known to require a speci®c DNA inhibitor, and suppresses its inhibitory activity pre- element such as E-box or p53 binding site. Examining venting the cell from undergoing growth arrest (Suzuki possible mechanisms of trans-repression, we found that et al., 1996). These pleiotropic functions of Tax aect co-expression of E47 and p300 activated E-box multiple regulatory processes of cells and are believed dependent transcription and this activation was eciently to play roles at least in the initial stage of repressed by Tax.
    [Show full text]
  • Transcrip\Onal and Epigene\C Changes During Heart Disease
    786/110 Transcrip)onal and Epigene)c Changes during Heart Disease Danish Sayed Unique Features of Heart • Involuntary, rhythmic, cyclic contractions • Terminally differentiated, postnatal myocytes increase in size not numbers for growth • Number of non myocytes (e.g. fibroblasts) is more (60-70%) compared to number of myocytes (~30%). Neonate Heart Postnatal Growth “Physiological” Adult Heart - Exercise - Hypertension - Pregnancy - Aortic Stenosis - Sarcomeric Gene mutation - Myocardial Infarction - Dilated Cardiomyopathy Physiological Pathological Hypertrophy Hypertrophy Dilatation and Failure Compensatory Decompensation Overload • Increase in cardiomyocyte size • Chamber dilatation and mass, resulting in enlarged heart • Decreased Ventricular Wall • Increase in generalized gene Thickness and Increased expression, superimposed with wall tension significant increase in specialized genes, fetal gene • Altered Ca+2 handling program • Increased wall thickness • Increased myocardial • Switch to glucose metabolism apoptosis for energy Compromised Maintained Cardiac Cardiac function and Function and Output Output Modulators of Cardiac Hypertrophy L-Type Ca+2 Ang II, ET-1 Channel α-Adrenergic β-Adrenergic Mechanical Ca+2 Insulin-like Growth Stretch + Factor Na Gq Gs P Ca+2 PKA PLC Adenylyl Integrin Cyclase Ca+2 RAS-GTP Na+ PI3K IP3 DAG cAMP Calcineurine FAK AKT Ca+2 Rho PKC PKA Ras mTOR Rac GSK3β 4EBP1 Rock MLCK NFAT MAPK eIF2B p70S6K eIF4E ME ME ME ME GATA4 GATA4 MEF2 Sarcomere SRF Translation AC AC Transcription HDAC Histone Acetylation HAT Modificatn. Methylation HMT Chromatin Demethylases Remodeling Phosphorylation DNA Methylation Transcriptional Modificatn. General Factors Transcription factors TFIIA, TFIIB, TFIID… Promoter Specific Factors GATA family, NFATc family Activity Recruitment Gene Regulation RNA Polymerase II Dynamics Initiation Elongation Translation factors e.g.
    [Show full text]
  • BMB400 Part Four - II = Chpt
    BMB400 Part Four - II = Chpt. 17. Transcriptional regulation by effects on RNA polymerase B M B 400 Part Four: Gene Regulation Section II = Chapter 17. TRANSCRIPTIONAL REGULATION EXERTED BY EFFECTS ON RNA POLYMERASE [Dr. Tracy Nixon made major contributions to this chapter.] A. The multiple steps in initiation and elongation by RNA polymerase are targets for regulation. 1. RNA Polymerase has to * bind to promoters, * form an open complex, * initiate transcription, * escape from the promoter, * elongate , and * terminate transcription. See Fig. 4.2.1. 2. Summarizing a lot of work, we know that: • strong promoters have high KB, high kf, low kr, and high rates of promoter clearance. • weak promoters have low KB, low kf, high kr, and low rates of promoter clearance. • moderate promoters have one or more "weak" spots. 3. To learn these facts, we need: • genetic data to identify which macromolecules (DNA and proteins) interact in a specific regulation event, and to determine which base pairs and amino acid residues are needed for that regulation event. • biochemical data to describe the binding events and chemical reactions that are affected by the specific regulation event. Ideally, we would determine all forward and reverse rate constants, or equilibrium constants (which are a function of the ratio of rate constants) if rates are inaccessible. Although, in reality, we cannot get either rates or equilibrium constants for many of the steps, some of the steps are amenable to investigation and have proved to be quite informative about the mechanisms of regulation. BMB400 Part Four - II = Chpt. 17. Transcriptional regulation by effects on RNA polymerase Fig.
    [Show full text]
  • Repressor to Activator Switch by Mutations in the First Zn Finger of The
    Proc. Nat!. Acad. Sci. USA Vol. 88, pp. 7086-7090, August 1991 Biochemistry Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: Is direct DNA binding necessary? (interleukin 1 indudbility/dexamethasone modulation/DNA-binding domain mutants/interleukin 6 and c-fos promoters) ANURADHA RAY, K. STEVEN LAFORGE, AND PRAVINKUMAR B. SEHGAL* The Rockefeller University, New York, NY 10021 Communicated by Igor Tamm, May 20, 1991 (receivedfor review March 15, 1991) ABSTRACT Transfection ofHeLa cells with cDNA vectors previous experiments in HeLa cells transfected with cDNA expressing the wild-type human glucocorticoid receptor (GR) vectors constitutively expressing the wild type (wt) but not enabled dexamethasone to strongly repress cytokine- and sec- the inactive carboxyl-terminal truncation mutants of GR, we ond messenger-induced expression of cotransfected chimeric observed that dexamethasone (Dex) strongly repressed the reporter genes containing transcription regulatory DNA ele- induction by interleukin 1 (IL-1), tumor necrosis factor, ments from the human interleukin 6 (IL-6) promoter. Deletion phorbol ester, or forskolin of IL-6-chloramphenicol acetyl- of the DNA-binding domain or of the second Zn finger or a transferase (CAT) constructs containing IL-6 DNA from point mutation in the Zn catenation site in the second finger -225 to +13. Dex also repressed induction of IL-6- blocked the ability of GR to mediate repression of the IL-6 thymidine kinase (TK)-CAT chimeric constructs containing promoter.
    [Show full text]
  • Molecular and Cellular Signaling
    Martin Beckerman Molecular and Cellular Signaling With 227 Figures AIP PRESS 4(2) Springer Contents Series Preface Preface vii Guide to Acronyms xxv 1. Introduction 1 1.1 Prokaryotes and Eukaryotes 1 1.2 The Cytoskeleton and Extracellular Matrix 2 1.3 Core Cellular Functions in Organelles 3 1.4 Metabolic Processes in Mitochondria and Chloroplasts 4 1.5 Cellular DNA to Chromatin 5 1.6 Protein Activities in the Endoplasmic Reticulum and Golgi Apparatus 6 1.7 Digestion and Recycling of Macromolecules 8 1.8 Genomes of Bacteria Reveal Importance of Signaling 9 1.9 Organization and Signaling of Eukaryotic Cell 10 1.10 Fixed Infrastructure and the Control Layer 12 1.11 Eukaryotic Gene and Protein Regulation 13 1.12 Signaling Malfunction Central to Human Disease 15 1.13 Organization of Text 16 2. The Control Layer 21 2.1 Eukaryotic Chromosomes Are Built from Nucleosomes 22 2.2 The Highly Organized Interphase Nucleus 23 2.3 Covalent Bonds Define the Primary Structure of a Protein 26 2.4 Hydrogen Bonds Shape the Secondary Structure . 27 2.5 Structural Motifs and Domain Folds: Semi-Independent Protein Modules 29 xi xü Contents 2.6 Arrangement of Protein Secondary Structure Elements and Chain Topology 29 2.7 Tertiary Structure of a Protein: Motifs and Domains 30 2.8 Quaternary Structure: The Arrangement of Subunits 32 2.9 Many Signaling Proteins Undergo Covalent Modifications 33 2.10 Anchors Enable Proteins to Attach to Membranes 34 2.11 Glycosylation Produces Mature Glycoproteins 36 2.12 Proteolytic Processing Is Widely Used in Signaling 36 2.13 Reversible Addition and Removal of Phosphoryl Groups 37 2.14 Reversible Addition and Removal of Methyl and Acetyl Groups 38 2.15 Reversible Addition and Removal of SUMO Groups 39 2.16 Post-Translational Modifications to Histones .
    [Show full text]
  • Solutions for Practice Problems for Molecular Biology, Session 5
    Solutions to Practice Problems for Molecular Biology, Session 5: Gene Regulation and the Lac Operon Question 1 a) How does lactose (allolactose) promote transcription of LacZ? 1) Lactose binds to the polymerase and increases efficiency. 2) Lactose binds to a repressor protein, and alters its conformation to prevent it from binding to the DNA and interfering with the binding of RNA polymerase. 3) Lactose binds to an activator protein, which can then help the RNA polymerase bind to the promoter and begin transcription. 4) Lactose prevents premature termination of transcription by directly binding to and bending the DNA. Solution: 2) Lactose binds to a repressor protein, and alters its conformation to prevent it from binding to the DNA and interfering with the binding of RNA polymerase. b) What molecule is used to signal low glucose levels to the Lac operon regulatory system? 1) Cyclic AMP 2) Calcium 3) Lactose 4) Pyruvate Solution: 1) Cyclic AMP. Question 2 You design a summer class where you recreate experiments studying the lac operon in E. coli (see schematic below). In your experiments, the activity of the enzyme b-galactosidase (β -gal) is measured by including X-gal and IPTG in the growth media. X-gal is a lactose analog that turns blue when metabolisize by b-gal, but it does not induce the lac operon. IPTG is an inducer of the lac operon but is not metabolized by b-gal. I O lacZ Plac Binding site for CAP Pi Gene encoding β-gal Promoter for activator protein Repressor (I) a) Which of the following would you expect to bind to β-galactosidase? Circle all that apply.
    [Show full text]
  • Mechanism of Promoter Repression by Lac Repressor–DNA Loops Nicole A
    156–166 Nucleic Acids Research, 2013, Vol. 41, No. 1 Published online 9 November 2012 doi:10.1093/nar/gks1011 Mechanism of promoter repression by Lac repressor–DNA loops Nicole A. Becker1, Justin P. Peters1, Troy A. Lionberger2 and L. James Maher III1,* 1Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, MN 55905, USA and 2Howard Hughes Medical Institute and Jason L. Choy Laboratory of Single-Molecule Biophysics, Department of Physics, University of California, Berkeley, CA 94720, USA Received June 29, 2012; Revised October 1, 2012; Accepted October 2, 2012 ABSTRACT presence of allolactose or its analog, isopropyl b-D-1- thiogalactopyranoside (IPTG), relieving repression. In the The Escherichia coli lactose (lac) operon encodes absence of glucose, RNA polymerase binds cooperatively the first genetic switch to be discovered, and lac with catabolite activator protein at the lac promoter (positive remains a paradigm for studying negative and control). In simplest terms, the mechanism of negative positive control of gene expression. Negative control involves Lac repressor binding to occlude access control is believed to involve competition of RNA of RNA polymerase holoenzyme to the lac promoter (4). polymerase and Lac repressor for overlapping Of particular significance to the present work is the binding sites. Contributions to the local Lac repres- fascinating observation that two remote auxiliary oper- sor concentration come from free repressor and re- ators (Oaux) exist in the lac operon (5). It has been pressor delivered to the operator from remote proposed and demonstrated (6–13) that bidentate repres- auxiliary operators by DNA looping.
    [Show full text]
  • Identification of a Family of Camp Response Element-Binding Protein Coactivators by Genome-Scale Functional Analysis in Mammalian Cells
    Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells Vadim Iourgenko*†, Wenjun Zhang*†, Craig Mickanin*, Ira Daly*, Can Jiang*, Jonathan M. Hexham*, Anthony P. Orth‡, Loren Miraglia‡, Jodi Meltzer*, Dan Garza*, Gung-Wei Chirn*, Elizabeth McWhinnie*, Dalia Cohen*, Joanne Skelton*, Robert Terry*, Yang Yu*, Dale Bodian*, Frank P. Buxton*, Jian Zhu*, Chuanzheng Song*, and Mark A. Labow*§ *Department of Functional Genomics, Novartis Institute for Biomedical Research, 100 Technology Square, Cambridge, MA 02139; and ‡Genomics Institute, Novartis Research Foundation, 10675 John Jay Hopkins Drive, Suite F117, San Diego, CA 92121 Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA, and approved July 30, 2003 (received for review May 8, 2003) This report describes an unbiased method for systematically de- of screening data and further experiments demonstrated that the termining gene function in mammalian cells. A total of 20,704 IL-8 promoter contained an unrecognized cAMP response predicted human full-length cDNAs were tested for induction of element (CRE)-like element that was activated by a protein, the IL-8 promoter. A number of genes, including those for cyto- termed transducer of regulated cAMP response element-binding kines, receptors, adapters, kinases, and transcription factors, were protein (CREB) TORC1, which is the founding member of a identified that induced the IL-8 promoter through known regula- conserved family of CREB coactivators. Thus, screening of tory sites. Proteins that acted through a cooperative interaction arrayed cDNAs represents an unbiased approach for identifica- between an AP-1 and an unrecognized cAMP response element tion of gene function and elucidation of pathways that regulate (CRE)-like site were also identified.
    [Show full text]
  • GENE REGULATION Differences Between Prokaryotes & Eukaryotes
    GENE REGULATION Differences between prokaryotes & eukaryotes Gene function Description of Prokaryotic Chromosome and E.coli Review Differences between Prokaryotic & Eukaryotic Chromosomes Four differences Eukaryotic Chromosomes Form Length in single human chromosome Length in single diploid cell Proteins beside histones Proportion of DNA that codes for protein in prokaryotes eukaryotes humans Regulation of Gene Expression in Prokaryotes Terms promoter structural gene operator operon regulator repressor corepressor inducer The lac operon - Background E.coli behavior presence of lactose and absence of lactose behavior of mutants outcome of mutants The Lac operon Regulates production of b-galactosidase http://www.sumanasinc.com/webcontent/animations/content/lacoperon.html The trp operon Regulates the production of the enzyme for tryptophan synthesis http://bcs.whfreeman.com/thelifewire/content/chp13/1302002.html General Summary During transcription, RNA remains briefly bound to the DNA template Structural genes coding for polypeptides with related functions often occur in sequence Two kinds of regulatory control positive & negative General Summary Regulatory efficiency is increased because mRNA is translated into protein immediately and broken down rapidly. 75 different operons comprising 260 structural genes in E.coli Gene Regulation in Eukaryotes some regulation occurs because as little as one % of DNA is expressed Gene Expression and Differentiation Characteristic proteins are produced at different stages of differentiation producing cells with their own characteristic structure and function. Therefore not all genes are expressed at the same time As differentiation proceeds, some genes are permanently “turned” off. Example - different types of hemoglobin are produced during development and in adults. DNA is expressed at a precise time and sequence in time.
    [Show full text]
  • What Makes the Lac-Pathway Switch: Identifying the Fluctuations That Trigger Phenotype Switching in Gene Regulatory Systems
    What makes the lac-pathway switch: identifying the fluctuations that trigger phenotype switching in gene regulatory systems Prasanna M. Bhogale1y, Robin A. Sorg2y, Jan-Willem Veening2∗, Johannes Berg1∗ 1University of Cologne, Institute for Theoretical Physics, Z¨ulpicherStraße 77, 50937 K¨oln,Germany 2Molecular Genetics Group, Groningen Biomolecular Sciences and Biotechnology Institute, Centre for Synthetic Biology, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands y these authors contributed equally ∗ correspondence to [email protected] and [email protected]. Multistable gene regulatory systems sustain different levels of gene expression under identical external conditions. Such multistability is used to encode phenotypic states in processes including nutrient uptake and persistence in bacteria, fate selection in viral infection, cell cycle control, and development. Stochastic switching between different phenotypes can occur as the result of random fluctuations in molecular copy numbers of mRNA and proteins arising in transcription, translation, transport, and binding. However, which component of a pathway triggers such a transition is gen- erally not known. By linking single-cell experiments on the lactose-uptake pathway in E. coli to molecular simulations, we devise a general method to pinpoint the particular fluctuation driving phenotype switching and apply this method to the transition between the uninduced and induced states of the lac genes. We find that the transition to the induced state is not caused only by the single event of lac-repressor unbinding, but depends crucially on the time period over which the repressor remains unbound from the lac-operon. We confirm this notion in strains with a high expression level of the repressor (leading to shorter periods over which the lac-operon remains un- bound), which show a reduced switching rate.
    [Show full text]